甲状腺癌

• 耳_甲状腺_DOC(Weekly)+Rad

頭頚部癌

• 耳_頭頚部FC+Pembro_q3W
• 耳_頭頚部CBDCA+PTX(2W1R)+Cet(Weekly)2-
• 耳_頭頚部CBDCA+PTX(2W1R)+Cet(Weekly)1st
• 耳_頭頚部CBDCA+5FU[FC]_q3W
• 耳_頭頚部FC(q3W)+Cet(Weekly)(外来用)_2-
• 耳_頭頚部FC(q3W)+Cet(Weekly)(外来用)_1st
• 耳_頭頚部Pembrolizumab_q6W
• 耳_頭頚部_CBDCA(Weekly)+Rad
• 耳_頭頚部_Cetuximab(weekly 2~)+Rad
• 耳_頭頚部_Cetuximab(weekly 1st)+Rad
• 耳_頭頚部_CDDP(Weekly)+Rad
• 耳_頭頚部_DOC+CBDCA_q3W
• 耳_頭頚部_DOC_q3W
• 耳_頭頚部_Nivolumab(240mg_body)_q2W
• 耳_頭頚部_DOC+CDGP_q4W
• 耳_頭頚部_Cetuximab(weekly)_2~
• 耳_頭頚部_PTX6W1R
• 耳_頭頚部_PTX+Cet_Weekly_1st
• 耳_頭頚部_Nivolumab(3mg_kg)_q2W
• 耳_頭頚部_PTX+Cet_Weekly_2~